Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
Tipo de documento
Intervalo de ano de publicação
1.
Environ Sci Pollut Res Int ; 30(49): 108051-108066, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37747609

RESUMO

The excessive utilization of fossil fuels has worsened global warming and exacerbated the levels of air pollution in the environment, forcing us to consider alternative fuels for compression ignition engines. The current research aims to explore the possibilities of renewable fuels outperforming diesel fuel in terms of combustion, performance, and emission characteristics. Biodiesel is an environmentally friendly and renewable alternative fuel. The major drawback of biodiesel is the significant rise in nitrogen oxide (NOx) emissions. The main novelty and objective of this research is to investigate the performance and emission characteristics of variable compression ratio diesel engine using DPA antioxidant additive. For this investigation, diesel, Jatropha biodiesel (B30) and 100 ppm of phenolic antioxidant diphenylamine (DPA) blended with B30 have been used as fuel named B30+DPA100. From experimental outcomes, the inclusion of diphenylamine to B30 blend resulted in brake-specific fuel consumption (BSFC) and exhaust gas temperature (EGT) being reduced by 8.86% and 4.12%, respectively, compared to B30. Simultaneously, there was a 1.11% increase in brake thermal efficiency (BTHE). The B30+DPA100 fuel blend demonstrates effective control over NOx and other emissions. The emissions of NOx, carbon monoxide (CO), hydrocarbon (HC), and smoke from the B30+DPA100 blend have shown a reduction of 6.8%, 5.34%, 7.86%, and 15.67%, respectively, when compared to diesel. However, there has been an increase in carbon dioxide (CO2) by 7.8%. One notable advantage of the B30+DPA100 blend is the significant decrease in NOx emissions. Additionally, the cylinder pressure for B30+DPA100 has been lowered by 4.93% compared to B30. On the other hand, the net heat release rate (NHR) has experienced a 1.72% increase. The particle size of different elements present in the crankcase oil has been calculated by Zetasizer Nano. The analysis revealed varying particle sizes for different elements in the crankcase oil: aluminum (2.724 µm), chromium (2.78 µm), iron (2.423 µm), and lead (2.587 µm).


Assuntos
Biocombustíveis , Jatropha , Biocombustíveis/análise , Antioxidantes , Difenilamina , Óxidos de Nitrogênio/análise , Óxido Nítrico , Gasolina/análise , Emissões de Veículos/análise , Monóxido de Carbono/análise
2.
IDrugs ; 8(10): 805-8, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16254797

Assuntos
Inibidores da Angiogênese/síntese química , Química Farmacêutica/métodos , Inibidores da Angiogênese/uso terapêutico , Benzamidas/farmacologia , Benzamidas/uso terapêutico , Química Farmacêutica/tendências , Ensaios Clínicos como Assunto/métodos , Comportamento Cooperativo , Difenilamina/análogos & derivados , Difenilamina/farmacologia , Difenilamina/uso terapêutico , Indústria Farmacêutica/métodos , Drogas em Investigação/uso terapêutico , Humanos , Lenalidomida , Marketing/métodos , Ftalazinas/farmacologia , Ftalazinas/uso terapêutico , Piperazinas/farmacologia , Piperazinas/uso terapêutico , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Proteínas Serina-Treonina Quinases/farmacologia , Proteínas Serina-Treonina Quinases/uso terapêutico , Pirazóis/farmacologia , Pirazóis/uso terapêutico , Piridinas/farmacologia , Piridinas/uso terapêutico , Quinolinas/síntese química , Quinolinas/farmacologia , Quinolinas/uso terapêutico , Receptores Proteína Tirosina Quinases/antagonistas & inibidores , Receptores Proteína Tirosina Quinases/síntese química , Receptores Proteína Tirosina Quinases/uso terapêutico , Receptor do Fator de Crescimento Transformador beta Tipo II , Receptores de Fatores de Crescimento Transformadores beta/antagonistas & inibidores , Receptores de Fatores de Crescimento Transformadores beta/uso terapêutico , Fator de Células-Tronco/antagonistas & inibidores , Fator de Células-Tronco/síntese química , Fator de Células-Tronco/uso terapêutico , Talidomida/análogos & derivados , Talidomida/farmacologia , Talidomida/uso terapêutico , Tiofenos/síntese química , Tiofenos/uso terapêutico , Fator A de Crescimento do Endotélio Vascular/antagonistas & inibidores , Fator A de Crescimento do Endotélio Vascular/farmacologia , Fator A de Crescimento do Endotélio Vascular/uso terapêutico
3.
Arch Toxicol ; 67(2): 120-5, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8481100

RESUMO

Amoscanate, a substance which damages photoreceptors, was administered orally to Wistar rats in doses of 10, 40, and 125 mg/kg body weight once daily for 3 or 10 days. At both times electroretinographic, ophthalmological, and histopathological examinations of the retina were carried out to compare the sensitivity of conventional methods and to test electroretinography (ERG) for suitability for use in toxicity studies. Time-dependent and dose-dependent effects were found by electroretinography and light microscopy. However, signs of retinal changes appeared earlier and more distinctly in the electroretinogram. Ophthalmological fundus examination in albino rats yielded no characteristic correlate. In conclusion, electroretinography constitutes a valuable supplement to histopathology and is suitable for use in toxicity studies.


Assuntos
Isotiocianatos , Retina/efeitos dos fármacos , Doenças Retinianas/diagnóstico por imagem , Animais , Sistema Nervoso Central/efeitos dos fármacos , Difenilamina/análogos & derivados , Difenilamina/toxicidade , Eletrorretinografia , Masculino , Microscopia , Oftalmoscopia , Radiografia , Ratos , Ratos Wistar , Retina/patologia , Doenças Retinianas/induzido quimicamente , Doenças Retinianas/patologia , Sensibilidade e Especificidade , Tiocianatos/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA